Takeaways: Cysklar gives Canada’s small cystinosis community a dedicated, easy‑to‑use…
-
-
Clinical Pipeline Health Canada clears CTA for AFTX-201 in BAG3 DCM, to be evaluated in Phase 1/2 UPBEAT trial
Takeaways: Health Canada’s CTA clearance positions Affinia among the first…
0 1 0April 6, 2026